Lv12
70 积分 2026-01-27 加入
Cytotoxic chemotherapy: clinical aspects
6小时前
已完结
Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology
6小时前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
9小时前
已完结
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
1天前
已完结
Bystander effect of antibody-drug conjugates: fact or fiction?
1天前
已关闭
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123
4天前
已关闭
Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis
6天前
已关闭
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
6天前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
11天前
已关闭
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
11天前
已完结
皖公网安备34019202002308
